These findings suggest that de novo CD5-positive diffuse large B-cell lymphomas (CD5+ DLBCLs) share the characteristics of actively proliferating cells in CLL/SLL. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.